CLRBD Stock UPDATES Cellectar Biosciences Inc. (CLRBD) 6.7400

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cellectar Biosciences Inc. (CLRBD) 6.7400 $CLRBD

Cellectar Biosciences to Host Conference Call on August 20th to Discuss Second Quarter 2014 Results and Provide Quarterly Update on Development Progress
GlobeNewswire - Mon Aug 18, 3:15PM CDT
Cellectar Biosciences, Inc. (Nasdaq:CLRB), a biopharmaceutical company developing innovative agents for the detection and treatment of cancer, announced that management will host a conference call and live webcast to discuss second quarter 2014 financial results and provide an update on each of its development programs on Wednesday, August 20th at 5:00 PM ET.

OTC Markets Group Congratulates Cellectar Biosciences on NASDAQ Listing
PR Newswire - Fri Aug 15, 8:29AM CDT
OTC Markets Group Inc. (OTCQX: OTCM) congratulates Cellectar Biosciences Inc., on its successful public offering and approval to list on The NASDAQ Capital Market, effective August 15, 2014. Cellectar previously traded on OTCQX®, the best marketplace for established U.S. and global companies operated by OTC Markets Group.

Cellectar Biosciences Announces Pricing of $12,500,000 Public Offering and Listing on The Nasdaq Capital Market
GlobeNewswire - Thu Aug 14, 6:40PM CDT
Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of cancer, announced today the pricing of an underwritten public offering of 3,333,333 shares of its common stock at a per share price of $3.75 and warrants to purchase up to the same number of shares of common stock at a per warrant price of $0.01; plus the issuance of approximately an additional 1,110,000 shares and warrants in consideration of the cancellation of $4,000,000 principal amount of convertible debentures plus accrued interest. The warrants are exercisable immediately and expire five years from their date of issuance. The warrants will have an exercise price of $4.68 per share and will trade on the NASDAQ Capital Market under the symbol "CLRBW."

Cellectar Biosciences Files Investigational New Drug Application to Evaluate I-131-CLR1404 in Clinical Trials in Relapsed or Refractory Multiple Myeloma
GlobeNewswire - Mon Aug 11, 7:00AM CDT
Cellectar Biosciences, Inc. (OTCQX:CLRB), announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA) to begin clinical study of I-131-CLR1404, a highly-selective, cancer-targeting radiopharmaceutical, in patients with relapsed/refractory multiple myeloma, an incurable cancer of plasma cells.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Breaking Down Oklahoma's Car Insurance Costs

Updated Category News Views 47

Understanding Car Insurance Dynamics in Oklahoma In the labyrinth of car insurance premiums, drivers in Oklahoma are left navigating a multitude of factors. A recent article from HelloNation, featuring insurance agent Bobby Williamson, dives into these elements with a candor that cuts through the fluff. Understanding what drives those numbers up or down isn't just for the...

Continue Reading
Johnson Controls FY26 Results Highlight Growth Momentum

Updated Category News Views 141

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

Continue Reading
Metropolitan at The 9 Unveils Major Renovation in 2026

Updated Category News Views 89

A Cleveland Gem Gets a Makeover Alright, listen up—Metropolitan at The 9 in Cleveland has undergone a massive facelift. We're talking about a complete overhaul of every single one of its 156 guestrooms and suites, new elevators, a refreshed lobby, and a reimagined Ledger Bar. Details and Delights in Every Corner Let's dig into the nitty-gritty. Guests are walking into...

Continue Reading
Classet and Reelist Revamp Frontline Hiring Methods

Updated Category News Views 0

Social Media's New Role in Hiring Who'd have thought? Scrolling through cat videos now lands you a job interview. The partnership between Classet and Reelist has thrown the hiring game a curveball, offering a seamless ride from a hashtagged post to a phone chat with an AI recruiter named Joy—and all in record time. For those looking to hire frontline or skilled trades...

Continue Reading
Shrieve Expands with Clear Solutions Takeover

Updated Category News Views 0

Strategic Acquisition with Environmental Edge Who'd have thought Shrieve Chemical and Clear Solutions would hitch their wagons? This move, caught from the windy plains of Texas to the greens of Shrewsbury, has all the makings of a sharp strategic pairing. Shrieve Chemical, backed by Gemspring Capital, has swallowed UK-based Clear Solutions, a feisty name in water-based...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 32

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Revamp Preschool Questions for Richer Conversations

Updated Category News Views 139

Preschoolers, those tiny agents of chaos, come home with stories that you'd need a magnifying glass to find. Ask 'em "How was school?" and you're met with blank stares or a one-liner. Tami Nix of Archway Academy has been at this game for over 40 years, and she's got a trick or six up her sleeve. Ditch the Generic: Get Specific Yep, those generic questions are about as...

Continue Reading
DIRECTV and DAZN: NBA Games Reach Local Fans

Updated Category News Views 53

DIRECTV Teams Up With DAZN: A Slam Dunk for NBA Fans DIRECTV just inked a deal with DAZN to broadcast games for five NBA teams—Cleveland Cavaliers, Indiana Pacers, Memphis Grizzlies, Minnesota Timberwolves, and San Antonio Spurs—across their territories. For fans, this means a whole lot more hoops action conveniently bundled into your TV package, right in your living...

Continue Reading
Alfa Laval's Earnings Rise Despite Soft Q4 Outlook

Updated Category News Views 61

Understanding Alfa Laval's Third Quarter Surge Alfa Laval's third quarter report isn't just another financial document; it's a reflection of the volatility and unpredictable nature of the engineering sector. Sure, revenues and earnings have shot up, but there's a hint of caution as we steer into the fourth quarter. Order intake—a term that gives every investor a reason...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 47

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading

Top 5 Most Recently Viewed Articles

RabitiAI: Revolutionizing AI Access with User-Centric Tools

Updated Category News Views 98

RabitiAI: Back to Basics in AI Technology RabitiAI is stepping boldly into the artificial intelligence field, prioritizing user experience and accessibility as its core principles. The expansion of AI into everyday life certainly brings a myriad of opportunities but also accompanying challenges. As technology becomes more nuanced, ensuring every individual can harness its...

Continue Reading
Class Action Update: ModivCare Investors Encouraged to Act Now

Updated Category News Views 113

ModivCare Inc. Investors: Important Class Action Information Investors in ModivCare Inc. have an important opportunity to engage in a class action lawsuit regarding alleged securities fraud. The Schall Law Firm, a prominent national firm specialized in shareholder rights litigation, is leading this initiative. The firm is calling on investors to participate and explore...

Continue Reading
Genco Shipping's Q4 Earnings: Solid Beats and Future Chills

Updated Category News Views 138

Genco Shipping & Trading (NYSE:GNK) unveiled its Q4 earnings on February 17, 2026, and traders are already buzzing. The company reported an earnings per share (EPS) of $0.39, a 5.41% beat over the estimated $0.37. That’s a nice upside surprise for anyone holding GNK right now. Earnings Breakdown: Numbers That Matter Revenue was up by $10.72 million from last year, which...

Continue Reading
Telvantis Secures $45 Million Facility for Rapid Expansion

Updated Category News Views 158

Telvantis Enhances Financial Stability with New Facility Telvantis, formerly known as Raadr, has announced a strategic development by securing a $45 million working capital facility. This significant financial move is set to boost the company's growth plans and reinforce its operational foundation. The new funding arrangement will help Telvantis lower fixed-interest...

Continue Reading
Tom Lee Analyzes Bitcoin and Ethereum's Market Dynamics

Updated Category News Views 248

Understanding the Recent Crypto Decline Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) recently dropped below critical support levels, igniting discussions among investors regarding the underlying reasons for this decline. According to Tom Lee, a prominent strategist at Fundstrat, the downturn is not primarily due to macroeconomic factors but stems from a significant...

Continue Reading